<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9DC3CB67-AB5C-4DC1-B3D5-4390FC4078E3"><gtr:id>9DC3CB67-AB5C-4DC1-B3D5-4390FC4078E3</gtr:id><gtr:name>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DE8D69E5-6A9A-49AB-8D8C-E35A3FE51EF7"><gtr:id>DE8D69E5-6A9A-49AB-8D8C-E35A3FE51EF7</gtr:id><gtr:name>National Institute for Health and Welfare (THL)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9DC3CB67-AB5C-4DC1-B3D5-4390FC4078E3"><gtr:id>9DC3CB67-AB5C-4DC1-B3D5-4390FC4078E3</gtr:id><gtr:name>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DE8D69E5-6A9A-49AB-8D8C-E35A3FE51EF7"><gtr:id>DE8D69E5-6A9A-49AB-8D8C-E35A3FE51EF7</gtr:id><gtr:name>National Institute for Health and Welfare (THL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/586662E4-394A-4579-B9E1-8402D712887A"><gtr:id>586662E4-394A-4579-B9E1-8402D712887A</gtr:id><gtr:firstName>Geoff</gtr:firstName><gtr:surname>Garnett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100063"><gtr:id>FF9877BB-4BAB-44F9-9742-B016A7D9420C</gtr:id><gtr:title>Mathematical models and the epidemiology of sexually transmitted infections and HIV in industrialised populations</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100063</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>298290</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health and Welfare (THL)</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Dr Matti Lehtinen, Finish Public Health Institute</gtr:description><gtr:id>BEA24061-6B6C-4DCD-88F9-EC905893AAFA</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>dqpcftyAzBv-1</gtr:outcomeId><gtr:piContribution>Scientific; Ongoing; Sharing insights and data and developing phase IV community randomised HPV vaccination trials</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Professor King Holmes, University of Washington Seattle</gtr:description><gtr:id>297BCBD5-4D07-424F-A0A7-4130E0728AD3</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>KdX6HaqFTRi-1</gtr:outcomeId><gtr:piContribution>Scientific; Ongoing; Sharing insights and data - collaboration on a community randomised trial of STD screening and treatment in urban Peru.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Sevgi Aral, US Centers For Disease Control</gtr:description><gtr:id>08B0DE98-CDD0-4F5D-AF4C-06F67F7B2DAD</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>NzLMZAseDXV-1</gtr:outcomeId><gtr:piContribution>Scientific; Ongoing; Sharing insights</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Jackie Cassels, University of Sussex</gtr:description><gtr:id>1848C96C-7E6D-4C6C-9497-65CF133B7888</gtr:id><gtr:impact>Scientific; Ongoing; Sharing insights and data</gtr:impact><gtr:outcomeId>JpFSp9NyaEw-1</gtr:outcomeId><gtr:piContribution>Scientific; Ongoing; Sharing insights and data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>UNAIDS</gtr:description><gtr:id>0E0A1E3D-0101-4095-9DE4-046CE802838E</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>rM15ZviEJCT-1</gtr:outcomeId><gtr:piContribution>Scientific and funding; Sharing insights</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Anne Johnson; University College London</gtr:description><gtr:id>771F378A-21B1-43E4-BBD1-B81559C8446F</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>MsFHKqMQukh-1</gtr:outcomeId><gtr:piContribution>Sharing insights and data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Modelling the impact of HSV-2 vaccines</gtr:description><gtr:id>2BE3991B-CE22-4279-8022-C91F9FA07591</gtr:id><gtr:impact>Lead to a phase 3 trial funded by the uS NIH</gtr:impact><gtr:outcomeId>AC1F55B62AF-1</gtr:outcomeId><gtr:partnerContribution>Access to trial results prior to publication</gtr:partnerContribution><gtr:piContribution>Work to explore the potential impact of HSV-2 vacciones</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Reference Group</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E42461BC-A320-408D-A83D-0866575B2DD6</gtr:id><gtr:impact>Chair UNAIDS Reference Group on Estimates Models and Projections

Generation of estimates and trends in HIV globally</gtr:impact><gtr:outcomeId>955FB1E8C87</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8E685934-817F-4F6C-91B2-EC8C6482A8C1</gtr:id><gtr:impact>Plenary Lecture AIDS 2008

Press conference and report in Science</gtr:impact><gtr:outcomeId>BCB8ED92D53</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member Expert Advisory Group on AIDS</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>57B95D6F-00F9-46C7-AF04-66C0DBB45998</gtr:id><gtr:impact>Regular expert advice to DoH

Letter from CMO</gtr:impact><gtr:outcomeId>796441902BA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Comittee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>BA546B1D-B0D2-47FC-89A1-52B0953EDB0B</gtr:id><gtr:impact>Member WHO Committee on Health Statistics

Development of methods</gtr:impact><gtr:outcomeId>5DE36191B50</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Henry Wellcome Post Doctoral Fellowship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3660C28F-F399-487A-BEFC-E8566D733131</gtr:id><gtr:outcomeId>E57EE9C28330</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Henry Wellcome Fellowship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>39E25094-3D80-43B6-891A-2F86F16B7959</gtr:id><gtr:outcomeId>C5A693222910</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU Commission LSHC-CT-2004-503465 Cancer control using population-based registries and biobanks (CCPRB) 6m euros across 22 participants</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>5661AFF7-DAD2-4F62-95FA-97A004E0286A</gtr:id><gtr:outcomeId>piBWeUZYtGs0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2004-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>470000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (Developing and applying theoretical frameworks in the epidemiology of sexually transmitted infections)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>DA63D167-AE8C-45EF-88B2-79061F903F80</gtr:id><gtr:outcomeId>7DDF5B7DF160</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Expert Advisory Committee on AIDS</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>944E30E9-6D8D-46FE-9E5D-C9E0A8C3EA6D</gtr:id><gtr:impact>Policy on AIDS; Developed strateges for early identification of HIV infections</gtr:impact><gtr:outcomeId>D154B8E7274</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A model to calculate pattern of expect HIV impact over the next year 'Modes of Transmission' is being used by UNAIDS and WHO with countries</gtr:description><gtr:id>5CDBB302-8C43-4D7F-A02C-E8FD7EBADA5E</gtr:id><gtr:impact>This has lead to more focussed prevantion and an acknowledgement of previously ignored risk groups</gtr:impact><gtr:outcomeId>F7BBC69EDC2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Modes of Transmission</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>08ED56AB-3D21-4E15-9EDA-F478A123AF25</gtr:id><gtr:title>Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>XmmoeeWCL8Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E7F20F8-34D9-4D39-B90B-0BD5F3D98105</gtr:id><gtr:title>Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84c1622aad75ffd3c4e1ec68b446b3e8"><gtr:id>84c1622aad75ffd3c4e1ec68b446b3e8</gtr:id><gtr:otherNames>French KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>AE3BCD1B56E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD75D14-15AA-4525-92A1-ADE7CCFBEB61</gtr:id><gtr:title>Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/767e26e459f263f3a394b81f5455d1db"><gtr:id>767e26e459f263f3a394b81f5455d1db</gtr:id><gtr:otherNames>Lewis JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>E8935C30BD2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>192C7F06-60DA-4111-8208-AE8856F039B5</gtr:id><gtr:title>Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63a2a576a8dc842cec107cd025ae0875"><gtr:id>63a2a576a8dc842cec107cd025ae0875</gtr:id><gtr:otherNames>Choi YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5AC84BF3F28</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B946DDA0-DA3A-4664-9A63-0E92BDA333E9</gtr:id><gtr:title>Estimating duration in partnership studies: issues, methods and examples.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4227b50b4203ca62e05020243a8239eb"><gtr:id>4227b50b4203ca62e05020243a8239eb</gtr:id><gtr:otherNames>Burington B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>UoHvLEFz2nT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E20FB5E-7119-46E7-9112-D575BFAA932F</gtr:id><gtr:title>An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06508460b0bd55a7a747d5d2e4d29ab4"><gtr:id>06508460b0bd55a7a747d5d2e4d29ab4</gtr:id><gtr:otherNames>Looker KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>17E80C44CBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D201F842-2A6D-4328-A1C0-E16C9758BB11</gtr:id><gtr:title>Human papillomavirus and HPV vaccines: a review.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70493321aca8d13158e1503e4ee860d4"><gtr:id>70493321aca8d13158e1503e4ee860d4</gtr:id><gtr:otherNames>Cutts FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>585d6388c56cc4.75639073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC3811F2-9430-421D-94FF-7A6A336D8A37</gtr:id><gtr:title>Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8fa3e311c4f6e1e8f3a5e0ddf1c1d88"><gtr:id>a8fa3e311c4f6e1e8f3a5e0ddf1c1d88</gtr:id><gtr:otherNames>Dodd PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0025-5564</gtr:issn><gtr:outcomeId>Re2Esbk6Be9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DA20332-F775-46FC-8E3B-E8E424CDECD1</gtr:id><gtr:title>Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from Zimbabwe.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25fb1b9671ec61a32d2c1a5b1b78964"><gtr:id>c25fb1b9671ec61a32d2c1a5b1b78964</gtr:id><gtr:otherNames>Gregson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>DqKxHfs5bAB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A69D4B48-E0E4-4C7A-A411-4007C68E6249</gtr:id><gtr:title>Superinfection with a heterologous HIV strain per se does not lead to faster progression.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5728baf00e704d0c39290d33723c1495"><gtr:id>5728baf00e704d0c39290d33723c1495</gtr:id><gtr:otherNames>Fung IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0025-5564</gtr:issn><gtr:outcomeId>LoRaFR1VAqW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08C06BA-934D-4CB1-9087-3D6620F398F0</gtr:id><gtr:title>Self-medication prevalence for sexually transmitted diseases: meta-analysis and meta-regression of population level determinants.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/953660ac4c5377b735698d2f07236a37"><gtr:id>953660ac4c5377b735698d2f07236a37</gtr:id><gtr:otherNames>Gomez GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>96EFB2DE571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08209BC7-72CF-4153-A73A-EB3AA74D1EF8</gtr:id><gtr:title>Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b06fe73fe9ff6ae95b9277b2283e8bf"><gtr:id>7b06fe73fe9ff6ae95b9277b2283e8bf</gtr:id><gtr:otherNames>Williams JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>B96A2D3A216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC9D5A8-829A-494A-8C74-AEF3129DB237</gtr:id><gtr:title>How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaa2a92ba9834e0fc203fb04c33f2c2b"><gtr:id>eaa2a92ba9834e0fc203fb04c33f2c2b</gtr:id><gtr:otherNames>Mercer CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>2E1AC8B7892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F81B52A-5808-4D7A-B7F5-528CC74BC1AA</gtr:id><gtr:title>Seroepidemiology as basis for design of a human papillomavirus vaccination program.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e037b7302e213a35b4095673bb9d821b"><gtr:id>e037b7302e213a35b4095673bb9d821b</gtr:id><gtr:otherNames>Ryding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>B92AB8DACA0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B52D133-BB62-4AB0-955C-AE2C275EBDEF</gtr:id><gtr:title>Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>B2B488BF85F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A35F6EEA-CCF3-420D-A826-4B80C1810DFF</gtr:id><gtr:title>The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>8B049E2819F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100063</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>